Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05006638
Other study ID # MD27/2021
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date December 2022
Est. completion date December 2023

Study information

Verified date August 2022
Source Ain Shams University
Contact Aya Sabry Mohamed
Phone +201013910938
Email dr.ayasabry@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intravenous lipid emulsion is an established, effective treatment for local anesthetic systemic toxicity. It is also efficacious in animal models of severe cardiotoxicity caused by a number of other medications. Recent case reports of successful resuscitation suggest the efficacy of lipid emulsion infusion for treating non-local anesthetic overdoses across a wide spectrum of drugs. The present study will focus on the potential role of intravenous lipid emulsion as an adjuvant therapy in pesticides toxicity.


Recruitment information / eligibility

Status Recruiting
Enrollment 62
Est. completion date December 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients with acute pesticide intoxications with poison severity score 2 or 3 admitted in ICU of PCC-ASUH Exclusion Criteria: - Patients less than 18 years and more than 65 years. - Pregnant and lactating females. - Presence of medical diseases (e.g. renal, hepatic, cardiovascular, neurological diseases and chronic pancreatitis.) - Allergy to soya-, egg-or peanut protein

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Lipid Emulsion, Intravenous
Lipid emulsion is a mixture of soybean oil, egg phospholipids, glycerine, and is available in 10%, 20%, and 30% strengths. It has been used for decades as parenteral nutrition and for caloric supplementation and essential fatty acid deficiency. It has also been used as a carrier for lipid soluble medications
Atropine
a drug used as an antidote for some types of pesticides
Toxogonin
a drug used as an antidote for some types of pesticides
Sodium Bicarbonate Powder and ondansetron
standard of care for treatment of aluminuim phosphide is provided for patients poisoned with aluminuim phosphide

Locations

Country Name City State
Egypt Poison Control Center of Ain-Shams University hospitals Cairo Abbasya

Sponsors (1)

Lead Sponsor Collaborator
Aya Sabry Mohamed Mohamed

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary mortality rate reduction the primary end point is to lower the mortality rate for patients poisoned with pesticides 1 year
Primary organ damage reduction another primary end point is to reduce organ damage and injury for survivors 1 year
See also
  Status Clinical Trial Phase
Completed NCT02986763 - Evaluation of Pesticide Exposure in the General Population N/A
Active, not recruiting NCT03925025 - Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning Phase 3
Completed NCT03647020 - Impact of Oocytes With CLCG on ICSI Outcomes and Their Potential Relation to Pesticide Exposure
Completed NCT01146496 - A Community Trial to Determine Whether 'Safe Storage' Reduces Pesticide Self-poisoning in Rural Asia N/A
Not yet recruiting NCT05310188 - Cholinesterase, Amylase, Lipase and Neutrophil-to-lymphocyte Ratio in Acute Pesticide Poisoning Cases